GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz Post author:Sam Post published:February 4, 2018 Post category:BioPharma Companies including Sanofi, J&J, Nestle have dropped out. Source: BioSpace You Might Also Like FDA Expands Bristol-Myers Squibb’s Opdivo Dosing Schedule March 5, 2018 Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million February 20, 2017 3 Biotechs the Super-Rich Regret Buying in 2017 (So Far) March 22, 2017
Sarepta Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead for $125 Million February 20, 2017
